AMEX:MNK (Ireland)  
Mallinckrodt PLC logo

Mallinckrodt PLC

$ 10.50 -0.2 (-1.87%) 10:08 PM EST
On watch
P/E:
At Loss
P/B:
0
Market Cap:
$ 138.29M
Enterprise V:
$ 2.83B
Volume:
15.73K
Avg Vol (2M):
23.95K
Also Trade In:
Volume:
15.73K
Market Cap $:
138.29M
PE Ratio:
At Loss
Avg Vol (2-Month):
23.95K
Enterprise Value $:
2.83B
PB Ratio:
0
GF Score:
Year:
Not Enough Data to Display
To
10Y: -%
Above Low: +NaN%
Below High: NaN%
Not Enough Data to Display
Alerts Website SEC Filings Stock Report
Dataset
Financial Download

Business Description

Description
Mallinckrodt PLC develops, manufactures, markets, and distributes specialty pharmaceutical products and therapies. Its areas of focus include autoimmune and rare diseases in specialty areas like neurology, rheumatology, nephrology, pulmonology and ophthalmology; immunotherapy and neonatal respiratory critical care therapies; analgesics and gastrointestinal products. The company operates its business in two reportable segments namely Specialty Brands which includes innovative specialty pharmaceutical brands; and Specialty Generics which includes niche specialty generic drugs and active pharmaceutical ingredients. It generates maximum revenue from the Specialty Brands segment. Geographically, it derives a majority of revenue from the United States.
Name Current Vs Industry Vs History
Cash-To-Debt 0.13
Equity-to-Asset 0.3
Debt-to-Equity 1.67
Debt-to-EBITDA -8.97
Piotroski F-Score 2/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score -0.05
Distress
Grey
Safe
Beneish M-Score -2.52
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC

Momentum Rank

Name Current Vs Industry Vs History
5-Day RSI 16.47
9-Day RSI 18.38
14-Day RSI 21.44

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 2.78
Quick Ratio 1.41
Cash Ratio 0.5
Days Inventory 176.34
Days Sales Outstanding 74.71
Days Payable 27.89

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -0.6

Financials (Next Earnings Date:2023-02-13 Est.)

MNK's 30-Y Financials

Guru Trades

See Details
To
Not Enough Data to Display

Insider Trades

See Details
To
Not Enough Data to Display

Gurus Latest Trades with AMEX:MNK

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To
Not Enough Data to Display

Performance

Dividend
Log
To
Not Enough Data to Display

Annualized Return %

Symbol 1 Week 1 Month 3 Months 6 Months YTD 1 Year 3 Years 5 Years 10 Years

Total Annual Return %

Symbol 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Executives

Not Enough Data to Display

Valuation Box

Year:
Not Enough Data to Display

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 1,937.2
EPS (TTM) ($) -32.51
Beta 0
Volatility % 0
14-Day RSI 21.44
14-Day ATR ($) 0.59205
20-Day SMA ($) 11.90825
12-1 Month Momentum % 0
52-Week Range ($) 10.45 - 31
Shares Outstanding (Mil) 13.17

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 2
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Mallinckrodt PLC Filings

Document Form Filing Date
No Filing Data

Mallinckrodt PLC Analysis

Share your research

Headlines

See More
No news.